BlackRock Fund Advisors’s Biostage, Inc. Common Stock BSTG Stock Holding History

BlackRock Fund Advisors’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4K	Buy	4,230 +1,080	+34%	+$963	﹤0.01%	4110
2016 Q3	$3K	Buy	3,150 +345	+12%	+$371	﹤0.01%	4158
2016 Q2	$3K	Buy	2,805 +192	+7%	+$310	﹤0.01%	4199
2016 Q1	$5K	Buy	2,613 +462	+21%	+$766	﹤0.01%	4104
2015 Q4	$5K	Buy	+2,151	New	+$3K	﹤0.01%	4156
2015 Q2	–	Sell	-26,153	Closed	-$85K	–	3926
2015 Q1	$85K	Buy	26,153 +5,967	+30%	+$20.3K	﹤0.01%	3646
2014 Q4	$64K	Buy	20,186 +1,440	+8%	+$7.13K	﹤0.01%	3658
2014 Q3	$152K	Sell	18,746 -1,360	-7%	-$11.1K	﹤0.01%	3560
2014 Q2	$210K	Sell	20,106 -164,935	-89%	-$1.4M	﹤0.01%	3474
2014 Q1	$1.68M	Buy	185,041 +1,756	+1%	+$10.4K	﹤0.01%	3152
2013 Q4	$871K	Buy	+183,285	New	+$857K	﹤0.01%	3204

Other funds holding BSTG

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

WIC

Woodmont Investment Counsel Nashville, Tennessee $1.62B AUM 18.92% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Fund Advisors's BSTG Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Biostage, Inc. Common Stock (BSTG) stake by 34% in Q4 2016, buying an estimated $963 and bringing the position to 4,230 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #4110.

BlackRock Fund Advisors first reported a position in BSTG in Q4 2013 and has held it in 11 quarters since. The position peaked at $1.68M in Q1 2014. 27 funds tracked by Wall St. Rank hold BSTG as of Q4 2016.

BlackRock Fund Advisors held 4,230 shares of Biostage, Inc. Common Stock worth $4K as of Q4 2016.
BlackRock Fund Advisors bought 1,080 Biostage, Inc. Common Stock shares in Q4 2016, an estimated $963.
Biostage, Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #4110 holding.
BlackRock Fund Advisors first reported a position in Biostage, Inc. Common Stock in Q4 2013 and has held it in 11 quarters since.
BlackRock Fund Advisors's Biostage, Inc. Common Stock position peaked at $1.68M in Q1 2014.
27 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.